Oncology & Cancer

Managing ovarian cancer risk in women with BRCA1/2 genetic variants

BRCA1 and BRCA2 genetic variants are a clinically important risk factor for the development of ovarian and breast cancer, and women who carry these variants have a lifetime risk of ovarian cancer of 39%-44% and 11%-17%, respectively.

Oncology & Cancer

Study shows increased risk of breast cancer in transgender women

Transgender women (male sex assigned at birth, female gender identity) using hormone treatment show an increased risk of breast cancer compared with the general male population, finds a large Dutch study published by The ...

Immunology

Asthma answer may not be steroids for women

For women depending on steroids to treat severe asthma, their body's estrogen may not only be preventing the treatment from working effectively, but making the asthma worse, according to a recent Western study.

Oncology & Cancer

Total thyroidectomy improves HRQoL in Hashimoto thyroiditis

(HealthDay)—For patients with Hashimoto thyroiditis with persistent symptoms despite normal thyroid gland function, total thyroidectomy, but not medical management, improves health-related quality of life and fatigue, according ...

Arthritis & Rheumatism

Reproductive, hormonal factors tied to knee OA in women

(HealthDay)—Female reproductive and hormonal factors are associated with incidence of knee osteoarthritis (OA), according to a study published in the July issue of Arthritis & Rheumatology.

page 1 from 16